Healthcare - Biotechnology - NASDAQ - US
$ 9.0145
-1.48 %
$ 29.3 M
Market Cap
-0.53
P/E
BALANCE SHEET
46.1 M
ASSETS
8.14 M
LIABILITIES
37.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Surrozen, Inc.
| Current Assets | 41.1 M |
| Cash & Short-Term Investments | 36 M |
| Receivables | 2.15 M |
| Other Current Assets | 2.94 M |
| Non-Current Assets | 4.95 M |
| Long-Term Investments | 0 |
| PP&E | 3.86 M |
| Other Non-Current Assets | 1.09 M |
| Current Liabilities | 7.15 M |
| Accounts Payable | 525 K |
| Short-Term Debt | 4.99 M |
| Other Current Liabilities | 1.63 M |
| Non-Current Liabilities | 997 K |
| Long-Term Debt | 882 K |
| Other Non-Current Liabilities | 115 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 36.0 | 24.7 | 33.1 | 35.0 | 29.1 |
| Short Term Investments | 0 | 51.1 | 68.8 | 14.2 | 0 |
| Receivables | 2.2 | 2.0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.9 | 4.6 | 6.7 | 1.0 | 0.3 |
| Total Current Assets | 41.1 | 81.3 | 105.2 | 50.2 | 29.4 |
| PP&E | 3.9 | 6.9 | 9.4 | 11.4 | 12.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.4 | 21.7 | 0.4 | 0 |
| Other Long Term Assets | 1.1 | 0.8 | 1.0 | 39 K | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 46.1 | 89.4 | 137.2 | 62.1 | 42.5 |
| LIABILITIES | |||||
| Accounts Payable | 0.5 | 0.7 | 2.7 | 1.8 | 1.0 |
| Short Term Debt | 5.0 | 4.5 | 4.4 | 2.1 | 1.5 |
| Other Current Liabilities | 1.6 | 4.6 | 6.5 | 3.4 | 1.4 |
| Total Current Liabilities | 7.1 | 9.7 | 13.6 | 7.3 | 3.9 |
| Long Term Debt | 0.9 | 3.4 | 5.6 | 7.5 | 9.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.1 | 0.3 | 8.3 | 0 | 0 |
| Total Liabilities | 8.1 | 13.4 | 27.5 | 14.8 | 13.1 |
| EQUITY | |||||
| Common Stock | 0 | 3 K | 4 K | 2 K | 1 K |
| Retained Earnings | (221.7) | (178.7) | (142.6) | (88.0) | (55.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | (0.2) | (0.1) | 0 | 0 |
| Total Equity | 37.9 | 76.0 | 109.7 | 47.3 | 29.4 |
| Total Liabilities and Equity | 46.1 | 89.4 | 137.2 | 62.1 | 42.5 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 2.0 | 2.3 | 2.3 | 0.8 | 0.4 |